Gene · 4928
Papers2,783
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,783
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Warning Transition Points from Hepatitis B to Hepatocellular Carcinoma Based on Mutation Accumulation for the Early Diagnosis and Potential Drug Treatment of HBV-HCC. | Oxid Med Cell Longev | 2022 | 36105485 | PubTator, text mining | PubMed |
| Regulating Phase Transition in Neurodegenerative Diseases by Nuclear Import Receptors. | Biology (Basel) | 2022 | 36101390 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients. | PLoS Genet | 2022 | 36095024 | PubTator, text mining | PubMed |
| GPR125 (ADGRA3) is an autocleavable adhesion GPCR that traffics with Dlg1 to the basolateral membrane and regulates epithelial apicobasal polarity. | J Biol Chem | 2022 | 36089063 | PubTator, text mining | PubMed |
| Phase separation in immune regulation and immune-related diseases. | J Mol Med (Berl) | 2022 | 36085373 | PubTator, text mining | PubMed |
| Drosophila as a Model for Human Viral Neuroinfections. | Cells | 2022 | 36078091 | PubTator, text mining | PubMed |
| Reading and erasing of the phosphonium analogue of trimethyllysine by epigenetic proteins. | Commun Chem | 2022 | 36071790 | PubTator, text mining | PubMed |
| Components of the LINC and NPC complexes coordinately target and translocate a virus into the nucleus to promote infection. | PLoS Pathog | 2022 | 36067270 | PubTator, text mining | PubMed |
| Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19. | Eur J Med Chem Rep | 2022 | 36060987 | PubTator, text mining | PubMed |
| Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy. | Nat Commun | 2022 | 36057605 | PubTator, text mining | PubMed |
| Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients. | Blood Cancer J | 2022 | 36055992 | PubTator, text mining | PubMed |
| Nucleoporin 85 interacts with influenza A virus PB1 and PB2 to promote its replication by facilitating nuclear import of ribonucleoprotein. | Front Microbiol | 2022 | 36051755 | PubTator, text mining | PubMed |
| DNA-PAINT MINFLUX nanoscopy. | Nat Methods | 2022 | 36050490 | PubTator, text mining | PubMed |
| JMJD family proteins in cancer and inflammation. | Signal Transduct Target Ther | 2022 | 36050314 | PubTator, text mining | PubMed |
| Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis. | Ann Hematol | 2022 | 36038660 | PubTator, text mining | PubMed |
| Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic Strategies. | Biomedicines | 2022 | 36009521 | PubTator, text mining | PubMed |
| An Interpretable Machine-Learning Algorithm to Predict Disordered Protein Phase Separation Based on Biophysical Interactions. | Biomolecules | 2022 | 36009025 | PubTator, text mining | PubMed |
| SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export. | PLoS Pathog | 2022 | 36007063 | PubTator, text mining | PubMed |
| Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution. | Front Oncol | 2022 | 36003795 | PubTator, text mining | PubMed |
| Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate. | Front Oncol | 2022 | 36003793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4928/papers?page=31